The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Improving the sustainability of small-molecule API manufacturing is essential to ensuring the continued success of the pharmaceutical industry. For most APIs, however, evaluating the global warming ...

The Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Market Size is projected to grow at a CAGR of 8.2% from ...

(MENAFN- IMARC Group) Setting up an API Manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

Effective and safe APIs provide the necessary element of drugs to treat patients with a variety of health conditions. It is, therefore, crucial that the quality of APIs, along with other ingredients ...

Government regulations that favor API development and changes in geopolitical conditions are driving market expansion. The expansion is due to advancements in manufacturing active pharmaceutical ...

AbbVie (ABBV) announced a $195M investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient production in the U.S. This expansion is part of ...

SAN FRANCISCO, April 29, 2025 /PRNewswire/ -- The global active pharmaceutical ingredients market size is projected to reach USD 359.45 billion by 2030, and it is expected to exhibit a CAGR of 5.85% ...